Introduction: The Prevention of Cruelty to Animals Act (1960) and its implementing rules shape the ethical and regulatory landscape for preclinical testing in India. For M.Pharm students, understanding this law is essential because it governs the use of laboratory animals, mandates institutional oversight, enforces registration and inspection of animal facilities, and promotes alternatives to animal use. This blog presents focused MCQs to reinforce key concepts: CPCSEA oversight, Institutional Animal Ethics Committees (IAEC), the 3Rs (Replacement, Reduction, Refinement), record-keeping, and legal consequences of non-compliance. These questions will help students prepare for exams and for responsible conduct in preclinical research and regulatory submissions.
Q1. What is the primary purpose of the Prevention of Cruelty to Animals Act with respect to preclinical testing?
- To standardize drug dosages for animals used in research
- To regulate and prevent unnecessary pain and suffering of animals used in experiments
- To provide funding for animal research
- To replace all animal testing with in vitro methods immediately
Correct Answer: To regulate and prevent unnecessary pain and suffering of animals used in experiments
Q2. Which statutory body supervises the control and regulation of experiments on animals in India under the Act?
- Central Drugs Standard Control Organization (CDSCO)
- Indian Council of Medical Research (ICMR)
- Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA)
- Pharmacy Council of India (PCI)
Correct Answer: Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA)
Q3. Before initiating any animal experiment in an institution, which local body must approve the project?
- Institutional Review Board (IRB)
- Institutional Ethics Committee for Human Research (IECHR)
- Institutional Animal Ethics Committee (IAEC)
- Drug Controller General of India (DCGI)
Correct Answer: Institutional Animal Ethics Committee (IAEC)
Q4. Which of the following is a core principle promoted by CPCSEA and relevant to study design?
- 3Ps: Protect, Provide, Publish
- 3Rs: Replacement, Reduction, Refinement
- 4S: Safety, Speed, Statistics, Species
- 2C: Care and Control
Correct Answer: 3Rs: Replacement, Reduction, Refinement
Q5. Under the rules associated with the Act, what is mandatory for an animal facility that breeds animals for experiments?
- Registration with CPCSEA or designated authority
- Only monthly reporting to the head of the department
- No record-keeping is required
- Annual public exhibition of animals
Correct Answer: Registration with CPCSEA or designated authority
Q6. Which of the following members is typically required to be part of an Institutional Animal Ethics Committee (IAEC)?
- Only senior faculty from the same department conducting the experiments
- A veterinarian, a scientist experienced in animal experimentation, and a non-institutional member
- Only students who will perform the experiments
- A representative from the pharmaceutical company funding the study
Correct Answer: A veterinarian, a scientist experienced in animal experimentation, and a non-institutional member
Q7. If an institution conducts experiments without CPCSEA registration or IAEC approval, what consequence is most likely under the law?
- Mandatory promotion of the responsible investigator
- No consequence as long as results are published
- Penalties that may include fines, cancellation of registration, and legal action
- Automatic approval of the experiments retroactively
Correct Answer: Penalties that may include fines, cancellation of registration, and legal action
Q8. Which of the following best describes the concept of “Replacement” in the 3Rs?
- Replacing old personnel with trained staff in the animal house
- Substituting animals with non-animal methods or less sentient organisms wherever possible
- Replacing one species with a more expensive species to get reliable data
- Changing formulations to replace toxic ingredients
Correct Answer: Substituting animals with non-animal methods or less sentient organisms wherever possible
Q9. What is a humane endpoint in the context of preclinical animal studies?
- The moment when an animal first enters the laboratory facility
- A predefined point at which an animal is removed from the experiment to avoid unnecessary suffering
- The final day of the study irrespective of animal condition
- The time when experimental data collection begins
Correct Answer: A predefined point at which an animal is removed from the experiment to avoid unnecessary suffering
Q10. Which of the following practices is emphasized by CPCSEA to minimize pain during invasive procedures?
- Use of anesthesia and analgesia appropriate to the species and procedure
- Performing procedures only at night to reduce stress
- Avoiding documentation of analgesic use
- Only allowing untrained personnel to perform procedures to standardize outcomes
Correct Answer: Use of anesthesia and analgesia appropriate to the species and procedure
Q11. For regulatory submission of preclinical data, documentation of ethical clearance for animal studies should typically include:
- IAEC approval letter, study protocol, and detailed animal use records
- Only a verbal confirmation from the principal investigator
- An invoice for animal purchase only
- Photos of animals in cages without supporting records
Correct Answer: IAEC approval letter, study protocol, and detailed animal use records
Q12. Which of the following is a responsibility of the CPCSEA regarding institutions performing animal experiments?
- Setting international metabolite profiling standards
- Inspecting registered facilities and ensuring compliance with rules
- Approving marketing authorization for drugs
- Providing animal models for each research group
Correct Answer: Inspecting registered facilities and ensuring compliance with rules
Q13. Under the regulations, who is primarily responsible for ensuring that personnel handling animals are trained and competent?
- The study sponsor only
- The Institutional Animal Ethics Committee (IAEC) with institutional support
- The animal supplier only
- The journal where the study will be published
Correct Answer: The Institutional Animal Ethics Committee (IAEC) with institutional support
Q14. Which statement about the use of wild or endangered species in experiments under the Act is correct?
- Wild/endangered species can be used freely if the study is important
- Use of protected species is strictly regulated and often requires special permission
- There is no difference between using laboratory rodents and endangered species
- Researchers must only notify CPCSEA after using such species
Correct Answer: Use of protected species is strictly regulated and often requires special permission
Q15. What is the role of record-keeping in animal research per the applicable rules?
- Records are optional and only for large studies
- Maintain detailed records of animal acquisition, use, health, and disposition for inspection and transparency
- Records should be destroyed immediately after the study to protect confidentiality
- Only financial records need to be kept
Correct Answer: Maintain detailed records of animal acquisition, use, health, and disposition for inspection and transparency
Q16. Which of the following best describes the CPCSEA’s stance on publication and reporting of animal studies?
- There is no need to report experimental details in publications
- Transparent reporting (including ethical approval and welfare measures) is encouraged to ensure reproducibility and humane practice
- Only positive results should be reported
- Authors should hide methods to protect intellectual property
Correct Answer: Transparent reporting (including ethical approval and welfare measures) is encouraged to ensure reproducibility and humane practice
Q17. Which alternative methods are promoted to reduce animal use in preclinical testing?
- In vitro assays, computational modelling, and validated cell-based systems
- Increasing the number of animals per group to improve statistics
- Substituting mammals with primates exclusively
- Using unvalidated anecdotal methods
Correct Answer: In vitro assays, computational modelling, and validated cell-based systems
Q18. What specific documentation should an IAEC review before granting approval to a proposed animal experiment?
- Only the CV of the principal investigator
- Study protocol with justification for animal use, sample size calculation, 3R considerations, and welfare measures
- Only the budget of the project
- Marketing plan for the product being tested
Correct Answer: Study protocol with justification for animal use, sample size calculation, 3R considerations, and welfare measures
Q19. Which action best reflects the concept of “Refinement” in animal experimentation?
- Choosing a more aggressive experimental endpoint
- Modifying procedures to minimize pain, distress, or suffering and improve animal welfare
- Eliminating anesthesia to speed up procedures
- Using larger sample sizes without welfare considerations
Correct Answer: Modifying procedures to minimize pain, distress, or suffering and improve animal welfare
Q20. In case of an adverse event causing unexpected severe pain to animals during a study, what is the ethically and legally appropriate immediate action?
- Continue the experiment to collect data and report later
- Implement humane measures such as analgesia or euthanasia as appropriate and inform the IAEC and regulatory authority
- Hide the event from records to avoid penalties
- Increase the number of animals to compensate for losses
Correct Answer: Implement humane measures such as analgesia or euthanasia as appropriate and inform the IAEC and regulatory authority

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com

